Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder

European Journal of Oral Sciences

Volumn 106, Issue 6, 1998, Pages 992-998

  Kubota, Takao ^a   Kubota, Eiro ^a   Matsumoto, Atushi ^a   Kawai, Yoshiaki ^a   Saito, Hisashi ^a   Mikuni Takagaki, Yuko ^a   Sato, Sadao ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Matrix metalloproteinase 2; Matrix metalloproteinase 9; Synovial fluid; Temporomandibular joint

Indexed keywords

COLLAGEN; COLLAGENASE; GELATINASE; GELATINASE A; GELATINASE B; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DISLOCATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; IMMUNOBLOTTING; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; POLYACRYLAMIDE GEL ELECTROPHORESIS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDER;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COLLAGEN; COLLAGENASES; DISLOCATIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; GELATINASES; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032238025     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1998.eos106603.x     Document Type: Article

References (22)

1. MILAM SB, KLEBE RJ, TRIPLETT RG, HERBERT D. Characterization of extracellular matrix of the primate temporomandibular joint. J Oral Maxillofac Surg 1991; 49: 381-391.
2. QUINN JH. Arthroscopic and histologic evidence of chondromalacia in the temporomandibular joint. Oral Surg Oral Med Oral Pathol 1990; 70: 387-392.
3. KAPILA S, LEE C, RICHARDS DW. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells. J Dent Res 1995; 74: 1328-1336.
4. BRINCKERHOFF CE. Editorial: Joint destruction in arthritis: Metalloproteinases in the spotlight. Arthritis Rheum 1991; 34: 1073-1075.
5. MATRISIAN LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6: 121-125.
6. FREIJE JMP, DIEZ-ITZA I, BALBIN M, SANCHEZ LM, BLASCO R, TOLIVIA J, LOPEZ-OTIN C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16765-16773.
7. BASSETT P, BELLOQ JP, WOLF C, STOLL I, HUTIN P, LIMACHER JM, PODHAJCER OL, CHENARD MP, RIO MC, CHAMBON P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699-704.
8. MCNEILL C, ed. Temporomandibular disorders guidelines for classification, assessment and management, 2nd edition. Chicago, IL: Quintessence Publishing, 1993; 39-46.
9. KUBOTA E, IMAMURA H, KUBOTA T, SHIBATA T, MURAKAMI K-I. Interleukin 1β and stromelysin (MMP 3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997; 55: 20-27.
10. OVERALL CM, WRANA JL, SODEK J. Independent regulation of collagenase 72-kDa progelatinase, and matrixendoproteinase inhibitor (TIMP) expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989; 264: 1860-1869.
11. WOESSNER JF JR. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-2154.
12. BRECKON JJW, HEMBRY RM, REYNOLDS JJ, MEIKLE MC. Identification of matrix metalloproteinases and their inhibitor in articular disc of craniomandibular joint of the rabbit. Arch Oral Biol 1996; 41: 315-322.
13. LECO KJ, KHOKHA R, PAVLOFF N, HAWKES SP, EDWARDS DR. Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an extracellular matrix associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269: 9352-9360.
14. OLSON TM, HIROHATA S, YE J, LECO K, SELDIN MF, APTE SS. Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP-4) and timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively. Genomics 1998; 51: 148-151.
15. LOUMANDER LS, HOERRNER LA, LARK MW. Metalloproteinases, tissue inhibitor and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993; 36: 181-189.
16. FESSLER LI, DUNCAN KG, FESSLER JH, SALO T, TRYGGVASON K. Characterization of procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 1984; 259: 9783-9789.
17. NAGASE H, OKADA Y, SUZUKI K, ENGHILD JJ, SALVESEN G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991; 19: 715-718.
18. GRUBER BL, SORBI D, FRENCH DL, MARCHESE MJ, Nuovo GJ, KEW RR, ARBEIT LA. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin Immunol Immunopathol 1996; 78: 161-171.
19. REPONEN P, SAHLBERG C, MUNANT C, THESLEFP I, TRYGGVASON K. High expression of 92 kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 1994; 267: 7856-7862.
20. WUCHERPFENNIG AL, LI Y-P, STETLER-STEVENSON WG, ROSENBERG AE, STASHENKO P. Expression of 92 KD type IV collagenase/gelatinase B in human osteoclasts. J Bone Min Res 1994; 9: 549-556.
21. KUBOTA E, KUBOTA T, MATSUMOTO A, SHIBATA T, MURAKAMI K-I. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998; 56: 192-198.
22. MURPHY G, WILLENBROCK F, WARD RV, COOBETT MI, EATON D, DOCHERTY AJP. The c-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992; 283: 637-641.